Quantitative ultrasound for bone density measurement

  • Author(s) / Creator(s)
  • his report has been prepared in view of the increasing interest in ultrasound technology for diagnosis of osteoporosis. Until recently, quantitative ultrasound (QUS) was mainly being used in research settings. This procedure is still not covered by provincial fee schedules. The recent FDA pre-marketing approvals of the Hologic Sahara and Lunar Achilles devices for general use in the diagnosis of osteoporosis can be expected to increase interest in the use of this technology by both consumers and healthcare providers.

    The issues addressed in this report include the current status of quantitative ultrasound technology, its performance and predictive value compared to x-ray based technologies, availability of machines, and issues related to its use in Canada. HTA 11.

  • Date created
  • Subjects / Keywords
  • Type of Item
  • DOI
  • License
    Attribution-NonCommercial-NoDerivatives 4.0 International